Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 31, 2023

Real-World Effectiveness of COVID-19 Vaccines and Anti-SARS-CoV-2 Monoclonal Antibodies Against Post-Acute Sequelae of SARS-CoV-2 Infection

BMJ Open


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ Open
Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population
BMJ Open 2023 Apr 05;13(4)e067611, J Tannous, AP Pan, T Potter, AT Bako, K Dlouhy, A Drews, HD Sostman, FS Vahidy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading